SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-002961
Filing Date
2015-01-07
Accepted
2015-01-07 18:39:20
Documents
1
Period of Report
2015-01-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7654
  Complete submission text file 0001209191-15-002961.txt   9134
Mailing Address 2200 POWELL ST SUITE 220 EMERYVILLE CA 94608
Business Address 2200 POWELL ST SUITE 220 EMERYVILLE CA 94608 510-903-3402
Adamas Pharmaceuticals Inc (Issuer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ADAMAS PHARMACEUTICALS, INC. 2200 POWELL ST, STE 220 EMERYVILLE CA 94608
Business Address
McClure Natalie (Reporting) CIK: 0001604572 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36399 | Film No.: 15514549